BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 23535911)

  • 1. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
    Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Nakamura T; Teranishi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A; Hotta K
    Hum Genet; 2013 Jul; 132(7):783-92. PubMed ID: 23535911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population.
    Chung GE; Lee Y; Yim JY; Choe EK; Kwak MS; Yang JI; Park B; Lee JE; Kim JA; Kim JS
    Gut Liver; 2018 May; 12(3):316-323. PubMed ID: 29271184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
    Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
    Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rs5764455 and rs6006473 polymorphisms in PARVB with liver damage of nonalcoholic fatty liver disease in Han Chinese population.
    Wu G; Wang K; Xue Y; Song G; Wang Y; Sun X; Zhong L; Zhou C; Shen B; Chen J; Yu Y; Tang H; Peng Z; Sun P; Wang X
    Gene; 2016 Jan; 575(2 Pt 1):270-5. PubMed ID: 26343796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of
    Xu K; Zheng KI; Zhu PW; Liu WY; Ma HL; Li G; Tang LJ; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
    J Clin Transl Hepatol; 2022 Apr; 10(2):219-229. PubMed ID: 35528982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
    Lee KJ; Moon JS; Kim NY; Ko JS
    Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease.
    Kitamoto T; Kitamoto A; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    J Hum Genet; 2014 May; 59(5):241-6. PubMed ID: 24621583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
    Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
    J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population.
    Chen L; Lin Z; Jiang M; Lu L; Zhang H; Xin Y; Jiang X; Xuan S
    Hepat Mon; 2015 Oct; 15(10):e31076. PubMed ID: 26587038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms.
    Li Z; Shen W; Wu G; Qin C; Zhang Y; Wang Y; Song G; Xiao C; Zhang X; Deng G; Wang R; Wang X
    FEBS Open Bio; 2021 Jul; 11(7):1893-1906. PubMed ID: 33728819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.
    Kawaguchi T; Sumida Y; Umemura A; Matsuo K; Takahashi M; Takamura T; Yasui K; Saibara T; Hashimoto E; Kawanaka M; Watanabe S; Kawata S; Imai Y; Kokubo M; Shima T; Park H; Tanaka H; Tajima K; Yamada R; Matsuda F; Okanoue T;
    PLoS One; 2012; 7(6):e38322. PubMed ID: 22719876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
    Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
    Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
    Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
    PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
    Young KA; Palmer ND; Fingerlin TE; Langefeld CD; Norris JM; Wang N; Xiang AH; Guo X; Williams AH; Chen YI; Taylor KD; Rotter JI; Raffel LJ; Goodarzi MO; Watanabe RM; Wagenknecht LE
    Obesity (Silver Spring); 2019 Aug; 27(8):1331-1337. PubMed ID: 31219225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.
    Kanth VV; Sasikala M; Rao PN; Steffie Avanthi U; Rao KR; Nageshwar Reddy D
    World J Hepatol; 2014 Jun; 6(6):435-42. PubMed ID: 25018854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
    Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.